Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women

Kristine Yaffe, T. Blackwell, Rachel Whitmer, K. Krueger, E. Barrett-Connor

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Background: Biological mechanisms linking diabetes and cognition continue to grow, yet the association remains controversial in elders. Whether glycosylated hemoglobin (HbA 1C) level, a marker of glucose control, is predictive of the development of cognitive impairment or dementia is unknown. We determined the association between HbA 1C level and risk of developing cognitive impairment in older women, mostly without diabetes. Methods: We studied 1983 postmenopausal women (mean age, 67.2 years) with osteoporosis who had HbA 1C level measured at baseline. Development of mild cognitive impairment (MCI) or dementia over 4 years was determined as part of a dementia ancillary study. We analyzed risk of MCI or dementia for every 1% of HbA 1C as well as risk associated with HbA 1C ≥ 7%. Results: The mean level of HbA 1C was 5.8% (range 3.0% to 12.1%) and 86 (4.3%) women developed MCI or dementia. For every 1% increase in HbA 1C, women had a greater age-adjusted likelihood of developing MCI (OR=1.50; 95% CI 1.14-1.97) and of developing MCI or dementia (OR=1.40; 95% CI 1.08-1.83). For those with HbA 1C level ≥ 7% (n=49), the age-adjusted risk for developing MCI was increased nearly 4-fold (OR= 3.70; 95% CI 1.51-9.09) and was increased nearly 3-fold for developing MCI or dementia (OR=2.86; 95% CI 1.17-6.98). When we excluded women with diagnosed diabetes (n=53), the association between HbA 1C and MCI lessened somewhat but remained elevated (unadjusted OR=1.59; 95% CI 1.01-2.50; age-adjusted OR=1.42; 95% CI 0.89-2.28). Multivariate analyses adjusted for age, education, race, depression, alcohol use and treatment with raloxifene yielded similar results. Interpretation: We found an association between HbA 1C level and risk of developing MCI or dementia in postmenopausal osteoporotic women primarily without diabetes. Our findings support the hypothesis that glucose dysregulation is a predictor for cognitive impairment. The Journal of Nutrition, Health & Aging

Original languageEnglish (US)
Pages (from-to)292-295
Number of pages4
JournalJournal of Nutrition, Health and Aging
Volume10
Issue number4
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Glycosylated Hemoglobin A
Dementia
Cognitive Dysfunction
Glucose
Cognition
Osteoporosis
Multivariate Analysis
Alcohols
Depression

Keywords

  • Dementia
  • Diabetes
  • Glucose
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Geriatrics and Gerontology

Cite this

Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. / Yaffe, Kristine; Blackwell, T.; Whitmer, Rachel; Krueger, K.; Barrett-Connor, E.

In: Journal of Nutrition, Health and Aging, Vol. 10, No. 4, 01.07.2006, p. 292-295.

Research output: Contribution to journalArticle

Yaffe, Kristine ; Blackwell, T. ; Whitmer, Rachel ; Krueger, K. ; Barrett-Connor, E. / Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. In: Journal of Nutrition, Health and Aging. 2006 ; Vol. 10, No. 4. pp. 292-295.
@article{feaace201d1e455fb03d2e1826f33ff3,
title = "Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women",
abstract = "Background: Biological mechanisms linking diabetes and cognition continue to grow, yet the association remains controversial in elders. Whether glycosylated hemoglobin (HbA 1C) level, a marker of glucose control, is predictive of the development of cognitive impairment or dementia is unknown. We determined the association between HbA 1C level and risk of developing cognitive impairment in older women, mostly without diabetes. Methods: We studied 1983 postmenopausal women (mean age, 67.2 years) with osteoporosis who had HbA 1C level measured at baseline. Development of mild cognitive impairment (MCI) or dementia over 4 years was determined as part of a dementia ancillary study. We analyzed risk of MCI or dementia for every 1{\%} of HbA 1C as well as risk associated with HbA 1C ≥ 7{\%}. Results: The mean level of HbA 1C was 5.8{\%} (range 3.0{\%} to 12.1{\%}) and 86 (4.3{\%}) women developed MCI or dementia. For every 1{\%} increase in HbA 1C, women had a greater age-adjusted likelihood of developing MCI (OR=1.50; 95{\%} CI 1.14-1.97) and of developing MCI or dementia (OR=1.40; 95{\%} CI 1.08-1.83). For those with HbA 1C level ≥ 7{\%} (n=49), the age-adjusted risk for developing MCI was increased nearly 4-fold (OR= 3.70; 95{\%} CI 1.51-9.09) and was increased nearly 3-fold for developing MCI or dementia (OR=2.86; 95{\%} CI 1.17-6.98). When we excluded women with diagnosed diabetes (n=53), the association between HbA 1C and MCI lessened somewhat but remained elevated (unadjusted OR=1.59; 95{\%} CI 1.01-2.50; age-adjusted OR=1.42; 95{\%} CI 0.89-2.28). Multivariate analyses adjusted for age, education, race, depression, alcohol use and treatment with raloxifene yielded similar results. Interpretation: We found an association between HbA 1C level and risk of developing MCI or dementia in postmenopausal osteoporotic women primarily without diabetes. Our findings support the hypothesis that glucose dysregulation is a predictor for cognitive impairment. The Journal of Nutrition, Health & Aging",
keywords = "Dementia, Diabetes, Glucose, Mild cognitive impairment",
author = "Kristine Yaffe and T. Blackwell and Rachel Whitmer and K. Krueger and E. Barrett-Connor",
year = "2006",
month = "7",
day = "1",
language = "English (US)",
volume = "10",
pages = "292--295",
journal = "Journal of Nutrition, Health and Aging",
issn = "1279-7707",
publisher = "Springer Paris",
number = "4",

}

TY - JOUR

T1 - Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women

AU - Yaffe, Kristine

AU - Blackwell, T.

AU - Whitmer, Rachel

AU - Krueger, K.

AU - Barrett-Connor, E.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Background: Biological mechanisms linking diabetes and cognition continue to grow, yet the association remains controversial in elders. Whether glycosylated hemoglobin (HbA 1C) level, a marker of glucose control, is predictive of the development of cognitive impairment or dementia is unknown. We determined the association between HbA 1C level and risk of developing cognitive impairment in older women, mostly without diabetes. Methods: We studied 1983 postmenopausal women (mean age, 67.2 years) with osteoporosis who had HbA 1C level measured at baseline. Development of mild cognitive impairment (MCI) or dementia over 4 years was determined as part of a dementia ancillary study. We analyzed risk of MCI or dementia for every 1% of HbA 1C as well as risk associated with HbA 1C ≥ 7%. Results: The mean level of HbA 1C was 5.8% (range 3.0% to 12.1%) and 86 (4.3%) women developed MCI or dementia. For every 1% increase in HbA 1C, women had a greater age-adjusted likelihood of developing MCI (OR=1.50; 95% CI 1.14-1.97) and of developing MCI or dementia (OR=1.40; 95% CI 1.08-1.83). For those with HbA 1C level ≥ 7% (n=49), the age-adjusted risk for developing MCI was increased nearly 4-fold (OR= 3.70; 95% CI 1.51-9.09) and was increased nearly 3-fold for developing MCI or dementia (OR=2.86; 95% CI 1.17-6.98). When we excluded women with diagnosed diabetes (n=53), the association between HbA 1C and MCI lessened somewhat but remained elevated (unadjusted OR=1.59; 95% CI 1.01-2.50; age-adjusted OR=1.42; 95% CI 0.89-2.28). Multivariate analyses adjusted for age, education, race, depression, alcohol use and treatment with raloxifene yielded similar results. Interpretation: We found an association between HbA 1C level and risk of developing MCI or dementia in postmenopausal osteoporotic women primarily without diabetes. Our findings support the hypothesis that glucose dysregulation is a predictor for cognitive impairment. The Journal of Nutrition, Health & Aging

AB - Background: Biological mechanisms linking diabetes and cognition continue to grow, yet the association remains controversial in elders. Whether glycosylated hemoglobin (HbA 1C) level, a marker of glucose control, is predictive of the development of cognitive impairment or dementia is unknown. We determined the association between HbA 1C level and risk of developing cognitive impairment in older women, mostly without diabetes. Methods: We studied 1983 postmenopausal women (mean age, 67.2 years) with osteoporosis who had HbA 1C level measured at baseline. Development of mild cognitive impairment (MCI) or dementia over 4 years was determined as part of a dementia ancillary study. We analyzed risk of MCI or dementia for every 1% of HbA 1C as well as risk associated with HbA 1C ≥ 7%. Results: The mean level of HbA 1C was 5.8% (range 3.0% to 12.1%) and 86 (4.3%) women developed MCI or dementia. For every 1% increase in HbA 1C, women had a greater age-adjusted likelihood of developing MCI (OR=1.50; 95% CI 1.14-1.97) and of developing MCI or dementia (OR=1.40; 95% CI 1.08-1.83). For those with HbA 1C level ≥ 7% (n=49), the age-adjusted risk for developing MCI was increased nearly 4-fold (OR= 3.70; 95% CI 1.51-9.09) and was increased nearly 3-fold for developing MCI or dementia (OR=2.86; 95% CI 1.17-6.98). When we excluded women with diagnosed diabetes (n=53), the association between HbA 1C and MCI lessened somewhat but remained elevated (unadjusted OR=1.59; 95% CI 1.01-2.50; age-adjusted OR=1.42; 95% CI 0.89-2.28). Multivariate analyses adjusted for age, education, race, depression, alcohol use and treatment with raloxifene yielded similar results. Interpretation: We found an association between HbA 1C level and risk of developing MCI or dementia in postmenopausal osteoporotic women primarily without diabetes. Our findings support the hypothesis that glucose dysregulation is a predictor for cognitive impairment. The Journal of Nutrition, Health & Aging

KW - Dementia

KW - Diabetes

KW - Glucose

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=33748475644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748475644&partnerID=8YFLogxK

M3 - Article

C2 - 16886099

AN - SCOPUS:33748475644

VL - 10

SP - 292

EP - 295

JO - Journal of Nutrition, Health and Aging

JF - Journal of Nutrition, Health and Aging

SN - 1279-7707

IS - 4

ER -